Patent · US Active

IL-11 antibodies

US11078268B2 · kind B2 · utility

0Cited by
14References
11Claims
0Family size

Assignees

Inventors

Key dates

Filing dateDec 23, 2019
Grant dateAug 3, 2021
Priority date
Expiry dateDec 23, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/75
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

IL-11 antibodies are disclosed. Also disclosed are compositions comprising the IL-11 antibodies, and methods using the IL-11 antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.